Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/176327
Authors: 
Chowdhury, Nupur
Joshi, Pallavi
Patnaik, Arpita
Saraswathy, Arpita
Year of Publication: 
2015
Series/Report no.: 
Working Paper No. 309
Abstract: 
Drug Regulation has been the focus of several recent policy reform efforts in India, starting with the Mashelkar Committee Report in 2003 to the most recent report of the Ranjit Roy Chaudhary Committee in 2013. Nevertheless, the regulatory structure continues to be plagued with several structural challenges, including issues related to regulatory harmonisation between the centre and the states, access to regulatory resources, transparency, which have undermined the general effectiveness of the regulatory system. At the juncture when the Drugs and Cosmetics (Amendment) Bill, 2015 to amend the Drugs and Cosmetic Act, 1940, is expected to overhaul the drug regulation, this study, the first of its kind, evaluates the administrative structure and functions of drug regulatory authorities at both the federal and state level along with comparative perspectives on similar challenges from other international jurisdictions. Through legal and policy analysis, supported by stakeholder interactions, this study not only provides a systematic analysis of the current challenges, along with actionable policy recommendations and suggests possible means for their operationalisation.
Subjects: 
Government Policy
Regulation
Public Health
Environmental
Health
Safety Law
Illegal Behaviour and the Enforcement of Law
JEL: 
I18
K32
K42
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.